Radisens Diagnostics Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Radisens Diagnostics Ltd. - overview

Established

2009

Location

Cork, -, Ireland

Primary Industry

Medical Devices & Equipment

About

Radisens Diagnostics Ltd. develops advanced digital solutions focused on enhancing healthcare diagnostics through innovative technologies and efficient data management. Radisens Diagnostics Ltd. specializes in healthcare diagnostics, providing innovative solutions to improve medical testing efficiency.


Founded in 2009 and headquartered in Cork, Ireland, the company has previously raised EUR 1. 1 million in funding in June 2011 from Enterprise Ireland and Kernel Capital Partners. Radisens Diagnostics Ltd. offers a range of innovative digital healthcare solutions that aim to enhance the efficiency and accuracy of medical diagnostics.


Their core products focus on advanced diagnostic technologies designed for use in various clinical settings, catering primarily to healthcare providers and institutions looking to improve patient outcomes through reliable testing methodologies. The revenue model for Radisens Diagnostics Ltd. is based on the sales of its diagnostic solutions and services. The company engages in direct transactions with healthcare providers, allowing for the acquisition of its diagnostic tools that align with clinical needs.


While specific pricing details are not disclosed, the structure supports a straightforward purchasing process for clients, ensuring accessibility to high-quality diagnostic equipment. Radisens Diagnostics Ltd. plans to utilize the EUR 1. 1 million raised in June 2011 to expand its product offerings and enhance its technology infrastructure.


The company is working on developing new diagnostic tools aimed at improving healthcare accessibility, with expected launches in targeted global markets in the coming years. Specific regions for expansion include parts of Europe and North America, with initiatives projected to roll out by 2023.


Current Investors

Kernel Capital, Enterprise Ireland

Primary Industry

Medical Devices & Equipment

Sub Industries

Diagnostic Equipment, Monitoring Equipment

Website

www.radisens.com

Company Stage

Early Stage

Total Amount Raised

Subscriber access only

Radisens Diagnostics Ltd. - financials

Fiscal Year EndedDec 31, 2010Dec 31, 2011Dec 31, 2012Dec 31, 2013Dec 31, 2014Dec 31, 2015Dec 31, 2016Dec 31, 2017Dec 31, 2018Dec 31, 2019
Revenue (USD)----------
% Revenue Growth (YoY)----------
EBITDA (USD)----------
Operating Income (USD)----------
Operating Margin----------
% EBITDA Margin----------
NET Income (USD)(346,727)(838,899)(568,869)(625,670)(162,793)(467,109)269,148---
% Net Margin----------

Radisens Diagnostics Ltd. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Unspecified RoundCompletedRadisens Diagnostics Ltd.-

Displaying 1 - 1 of 1

Radisens Diagnostics Ltd. - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.